Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplasm, Residual × palbociclib × Clear all

NCT04130152 2022-10-25

PROMETEO II

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Neoplasm, Residual